SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-001293
Filing Date
2024-01-09
Accepted
2024-01-09 19:25:18
Documents
1
Period of Report
2024-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6680
  Complete submission text file 0001209191-24-001293.txt   8281
Mailing Address DAY ONE BIOPHARMACEUTICALS, INC. 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address
Dubow Adam (Reporting) CIK: 0001744507 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 24524554

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)